bpc-157 not approved by fda statement drug and the Difference Between an Evidence Gap and a The conversation around peptides just

Always consult a qualified healthcare professional before considering peptide use

Even the parent protein (TB4) failed to make it through the approval process

1 Targets Damaged Tissue BPC-157 binds to growth factor receptors in injured areas, initiating a cascade of healing signals

The potential of combining peptides for a multifaceted approach to weight control is also discussed, with a focus on the significance of responsible research use and more studies to demonstrate their efficacy

Malinda KM, Sidhu GS, Mani H, et al

Tissue Repair Compound Research blend of BPC-157 (15-mer gastric pentadecapeptide) and TB-500 (thymosin -4 actin-binding fragment) for comparative tissue-pathway studies in vitro